HealthCare Global Enterprises Limited (NSE:HCG)
543.50
-5.50 (-1.00%)
Jun 3, 2025, 3:29 PM IST
NSE:HCG Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 22,181 | 19,079 | 16,914 | 13,948 | 10,092 | Upgrade
|
Other Revenue | 47.1 | 42.48 | 30.33 | 30.05 | 42.5 | Upgrade
|
Revenue | 22,229 | 19,121 | 16,944 | 13,978 | 10,134 | Upgrade
|
Revenue Growth (YoY) | 16.25% | 12.85% | 21.22% | 37.92% | -7.50% | Upgrade
|
Cost of Revenue | 14,158 | 8,646 | 7,747 | 6,457 | 4,860 | Upgrade
|
Gross Profit | 8,071 | 10,475 | 9,198 | 7,521 | 5,274 | Upgrade
|
Selling, General & Admin | - | 619.64 | 448.05 | 273.86 | 189.58 | Upgrade
|
Other Operating Expenses | 4,198 | 6,553 | 5,442 | 4,869 | 3,826 | Upgrade
|
Operating Expenses | 6,312 | 8,921 | 7,842 | 6,725 | 5,608 | Upgrade
|
Operating Income | 1,759 | 1,555 | 1,355 | 795.46 | -333.74 | Upgrade
|
Interest Expense | -1,546 | -979.33 | -904.6 | -831.05 | -1,137 | Upgrade
|
Interest & Investment Income | - | 126.97 | 118.1 | 115.61 | 156.11 | Upgrade
|
Earnings From Equity Investments | 7.7 | 3.88 | -0.18 | -14.25 | -3.65 | Upgrade
|
Currency Exchange Gain (Loss) | - | 0.65 | -17.56 | -0.29 | -26.22 | Upgrade
|
Other Non Operating Income (Expenses) | 348.1 | -77.2 | -95.47 | -128.67 | -8.89 | Upgrade
|
EBT Excluding Unusual Items | 569.6 | 629.83 | 455.54 | -63.19 | -1,353 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -5.5 | - | Upgrade
|
Impairment of Goodwill | - | - | - | - | -130 | Upgrade
|
Gain (Loss) on Sale of Investments | - | 2.17 | 0.35 | 1.24 | 1.4 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -17.74 | -13.22 | -6.43 | -0.51 | Upgrade
|
Asset Writedown | - | - | - | -467.4 | -304.02 | Upgrade
|
Other Unusual Items | - | 63.03 | 6.13 | 1,419 | -500.43 | Upgrade
|
Pretax Income | 569.6 | 677.29 | 448.8 | 877.72 | -2,287 | Upgrade
|
Income Tax Expense | 81.3 | 263.95 | 272.5 | 488.47 | -75.61 | Upgrade
|
Earnings From Continuing Operations | 488.3 | 413.34 | 176.3 | 389.25 | -2,211 | Upgrade
|
Minority Interest in Earnings | -44.2 | 68.21 | 117.19 | 148.08 | 276.41 | Upgrade
|
Net Income | 444.1 | 481.55 | 293.49 | 537.33 | -1,935 | Upgrade
|
Net Income to Common | 444.1 | 481.55 | 293.49 | 537.33 | -1,935 | Upgrade
|
Net Income Growth | -7.78% | 64.08% | -45.38% | - | - | Upgrade
|
Shares Outstanding (Basic) | 139 | 139 | 139 | 130 | 114 | Upgrade
|
Shares Outstanding (Diluted) | 141 | 140 | 140 | 135 | 114 | Upgrade
|
Shares Change (YoY) | 0.73% | 0.50% | 3.35% | 18.95% | 28.34% | Upgrade
|
EPS (Basic) | 3.19 | 3.46 | 2.11 | 4.14 | -17.02 | Upgrade
|
EPS (Diluted) | 3.14 | 3.43 | 2.10 | 3.97 | -17.02 | Upgrade
|
EPS Growth | -8.46% | 63.33% | -47.10% | - | - | Upgrade
|
Free Cash Flow | 1,082 | 988.99 | 1,184 | 1,489 | 850.97 | Upgrade
|
Free Cash Flow Per Share | 7.65 | 7.04 | 8.47 | 11.01 | 7.49 | Upgrade
|
Gross Margin | 36.31% | 54.78% | 54.28% | 53.80% | 52.04% | Upgrade
|
Operating Margin | 7.92% | 8.13% | 8.00% | 5.69% | -3.29% | Upgrade
|
Profit Margin | 2.00% | 2.52% | 1.73% | 3.84% | -19.09% | Upgrade
|
Free Cash Flow Margin | 4.87% | 5.17% | 6.98% | 10.65% | 8.40% | Upgrade
|
EBITDA | 3,873 | 2,671 | 2,372 | 1,784 | 656.22 | Upgrade
|
EBITDA Margin | 17.42% | 13.97% | 14.00% | 12.76% | 6.48% | Upgrade
|
D&A For EBITDA | 2,113 | 1,116 | 1,017 | 988.67 | 989.96 | Upgrade
|
EBIT | 1,759 | 1,555 | 1,355 | 795.46 | -333.74 | Upgrade
|
EBIT Margin | 7.92% | 8.13% | 8.00% | 5.69% | -3.29% | Upgrade
|
Effective Tax Rate | 14.27% | 38.97% | 60.72% | 55.65% | - | Upgrade
|
Revenue as Reported | 22,577 | 19,291 | 17,076 | 14,105 | 10,304 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.